Triggering receptor expressed on myeloid cells 2 (TREM2) has been shown to play a role in the phagocytosis of apoptotic neuronal cells [124] and it has been recently identified as a microglial Aβ receptor that transduces physiological and AD-related pathological effects associated with Aβ [125]. This evidence concerns the gene TREM2 and Alzheimer disease.